Unidade Local De Saude De Matosinhos E.P.E.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Heart failure1 trial
• Lung cancer1 trial
• Multiple sclerosis1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Not yet recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Fundacion PETHEMA1 trial
• Institut De Recherches Internationales Servier IRIS1 trial
• Merck Sharp & Dohme LLC1 trial
• Sanofi1 trial

Running trials

• Not yet recruiting

  A study to compare heart failure medicines in one combined pill with usual care.

  2026-526510-90-00· Phase 3· Institut De Recherches Internationales Servier IRIS· Source

• Recruiting

  A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy

  2025-523238-17-00· Phase 2· Fundacion PETHEMA· Source

• Recruiting

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  NCT07325292· Phase 3· Sanofi· Source

• Recruiting

  Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  NCT06170788· Phase 3· Merck Sharp & Dohme LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Heart failure1 recruiting
• Lung cancer1 recruiting
• Multiple sclerosis1 recruiting